Adverse Event Reports

Your Safety is Our Priority

At Varifarma we are committed to not only developing high quality medicine, but also to guarantee the safety and wellbeing of those who trust in our products.

What is

Pharmacovigilance, also referred to as Adverse Event Reports, involves the ongoing process of monitoring and assessing the safety of medications after they have been authorized and made available to the public. The primary aim is to identify, appraise, comprehend, and avert any harmful effects or issues associated with the utilization of pharmaceuticals in order to safeguard the wellbeing of both patients and the wider community. The activities carried out by pharmacovigilance promote the rational and safe use of medicines for the benefit of our health.

Our Commitment to Safety

Safety of our patients is our top priority. Our team of pharmacovigilance experts works diligently to collect and analyse information about potential adverse effects of our products. This information comes from various sources, including health professionals, patients, and regulatory reports.

Reporting Suspected Adverse Effects

Pharmacovigilance is a shared responsibility between doctors, the pharmaceutical industry, local health authorities and patients. If you have experienced unexpected side effects while using one of our products, we encourage you to report it. Your contribution is essential to ensure the safety and quality of our products. You can report side effects through our contact channels below.

Transparency and Access to Information

We believe in transparency and open communication. Through our communication, reports, and continuous website updates we share our latest information. In addition, we closely collaborate with regulatory authorities to ensure our compliance with pharmacovigilance norms.

Our patients’ safety is essential for us, and we work diligently to ensure the highest quality and safety standards in our products.

Together we will build a healthier and safer future.


In case of suspected adverse events with any of our medicines, please do not hesitate to report them through the channels enabled by each of our subsidiaries in Latin America. Alternatively, you can also do so by completing the form below.


Uruguay 3698, (CP1643)
Beccar, Buenos Aires


Magnere 1540, Of. 307
(CP 7501587)
Santiago de Chile


Av. Dos de Mayo 1545,
Of. 502 D
San Isidro, 15073


Calle Pedro Ponce Carrasco
E8-06 y Av. Diego de Almagro
Ed. Almagro Plaza,
Oficinas 614-615
Quito, 170135


César Cortinas 2037, (CP 11500)
Montevideo, Uruguay